USPTO Examiner ARBLE JESSICA R - Art Unit 3781

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
18660859DRUG DELIVERY DEVICE AND METHODS FOR USING SAMEMay 2024January 2025Allow910NoNo
18642324OCULAR IMPLANTS FOR DELIVERY INTO AN ANTERIOR CHAMBER OF THE EYEApril 2024February 2025Allow1010NoNo
18639054APERTURED NONWOVEN WEBSApril 2024November 2024Allow710NoNo
18616791ABSORBENT ARTICLE WITH FUNCTION-FORMED TOPSHEET, AND METHOD FOR MANUFACTURINGMarch 2024June 2025Allow1410NoNo
18606596MEDICAL DEVICES FOR DELIVERING PLUGS TO VOIDSMarch 2024September 2024Allow600YesNo
18604007WOUND THERAPY SYSTEM WITH INSTILLATION THERAPY AND DYNAMIC PRESSURE CONTROLMarch 2024April 2025Allow1411YesNo
18586901HEMORRHAGE MANAGEMENT SYSTEMFebruary 2024September 2024Allow700NoNo
18425308DISPOSABLE ABSORBENT ARTICLEJanuary 2024November 2024Allow1010NoNo
18422954COMBINATION FLUID INSTILLATION AND NEGATIVE PRESSURE DRESSINGJanuary 2024March 2025Abandon1401NoNo
18397981WOUND CLOSURE DEVICE AND METHOD OF USEDecember 2023July 2024Allow700YesNo
18382247DRAINAGE SYSTEM WITH O-RINGOctober 2023May 2024Allow700NoNo
18368225SYSTEMS AND METHODS FOR REDUCING PRESSURE AT AN OUTFLOW OF A DUCTSeptember 2023August 2024Allow1110YesNo
18224454SYSTEMS AND METHODS FOR DETERMINING BLOCKAGES IN A NEGATIVE PRESSURE WOUND THERAPY SYSTEMJuly 2023April 2024Allow900YesNo
18207601WOUND TREATMENT APPARATUSES AND METHODS WITH NEGATIVE PRESSURE SOURCE INTEGRATED INTO WOUND DRESSINGJune 2023May 2025Allow2311NoNo
18254982WOUND DRESSINGMay 2023July 2024Allow1330YesNo
18321631Dispenser Actuator AssemblyMay 2023March 2025Allow2210NoNo
18123486CUSTOMIZABLE WOUND CLOSURE DEVICE AND METHOD OF USEMarch 2023June 2024Allow1510NoNo
18183849CONNECTED BODY SURFACE CARE MODULEMarch 2023October 2023Allow710YesNo
18111770HYBRID DRAPE HAVING A GEL-COATED PERFORATED MESHFebruary 2023March 2025Abandon2520NoNo
18111158PH SENSING FOR SENSOR ENABLED NEGATIVE PRESSURE WOUND MONITORING AND THERAPY APPARATUSESFebruary 2023June 2024Allow1610YesNo
18096937NEGATIVE PRESSURE WOUND TREATMENT APPARATUSES AND METHODS WITH INTEGRATED ELECTRONICSJanuary 2023June 2024Allow1710NoNo
18075582ABSORBENT ARTICLE WITH A DISTRIBUTION LAYER COMPRISING CHANNELSDecember 2022December 2024Allow2420NoNo
17991528SYSTEM AND METHOD FOR IMPROVING BATTERY LIFE OF PORTABLE NEGATIVE-PRESSURE THERAPY THROUGH HYSTERESIS CONTROLNovember 2022December 2023Allow1300NoNo
17773777DISPOSABLE WEARING ARTICLEOctober 2022June 2025Allow3710YesNo
17919624PANT-TYPE ABSORBENT ARTICLEOctober 2022June 2025Allow3210NoNo
17954950DEVICE AND METHOD FOR WOUND THERAPYSeptember 2022May 2025Abandon3110NoNo
17950495BLOOD RESERVOIR WITH BLOOD-HANDLING ASSEMBLYSeptember 2022March 2024Allow1810NoNo
17880132SKIN TREATMENT AND BEAUTY MANAGEMENT DEVICEAugust 2022July 2024Abandon2410NoNo
17853029WOUND DRESSING AND METHOD OF TREATMENTJune 2022June 2023Allow1111YesNo
17853139SYSTEMS AND METHODS FOR APPLYING REDUCED PRESSURE THERAPYJune 2022May 2025Allow3411YesNo
17780534DEVICE AND METHOD FOR AIR-FREE FILLING OF A FLUID MANAGEMENT SYSTEMMay 2022June 2025Allow3611NoNo
17717825DRY COSMETIC SHEETApril 2022May 2025Abandon3720NoNo
17766992APPARATUSES AND METHODS FOR NEGATIVE PRESSURE WOUND THERAPYApril 2022June 2025Allow3830NoNo
17691021ATTACHABLE TIP FOR ELECTROMAGNETIC HAND PIECEMarch 2022February 2024Allow2330NoYes
17682261DRUG DELIVERY DEVICE AND METHODS FOR USING SAMEFebruary 2022February 2024Allow2340YesNo
17587395AUTONOMOUS FLUID INSTILLATION SYSTEM AND METHOD WITH TISSUE SITE PRESSURE MONITORINGJanuary 2022February 2025Abandon3610NoNo
17578535FILTRATION DEVICE AND SYSTEMJanuary 2022March 2025Allow3811YesNo
17597167WOUND-COVERING MATERIAL AND PRODUCTION METHOD THEREFORDecember 2021March 2025Abandon3801NoNo
17563524DEVICES AND METHODS FOR TREATING AND CLOSING WOUNDS WITH NEGATIVE PRESSUREDecember 2021September 2024Abandon3301NoNo
17596702MEDICAL CONTAINER FOR FILLING WITH PROTEIN DRUGSDecember 2021November 2024Abandon3510NoNo
17523321DEVICES AND METHODS FOR DELIVERY OF PHARMACEUTICAL COMPOSITIONSNovember 2021August 2024Allow3350YesNo
17514527DRAINAGE SYSTEM WITH RETENTION RINGOctober 2021December 2024Allow3810NoNo
17513741APPARATUS AND METHOD FOR LOCATING FLUID LEAKS IN A REDUCED PRESSURE DRESSING UTILIZING A REMOTE DEVICEOctober 2021March 2025Abandon4010NoNo
17505305NEGATIVE PRESSURE WOUND CLOSURE DEVICEOctober 2021September 2024Abandon3501NoNo
17603631WOUND OXYGEN TREATMENT SYSTEMOctober 2021April 2025Allow4210NoNo
17495603INTERACTIVE TABLET AND INTEGRATED FACIAL TREATMENT DEVICEOctober 2021April 2022Allow710YesNo
17439582MEDICINAL PRODUCT COMPRISING A CONTAINER AND AN AQUEOUS LIQUID CONTAINING BICARBONATESeptember 2021September 2024Allow3610NoNo
17465816ON DEMAND DIALYSATE MIXING USING CONCENTRATESSeptember 2021July 2023Allow2200YesNo
17463079DRUG DELIVERY DEVICE AND METHODS FOR USING SAMEAugust 2021November 2021Allow300YesNo
17398426NEGATIVE POISSON`S RATIO MATERIALS FOR MEDICAL APPLICATIONSAugust 2021January 2025Allow4111NoNo
17395857DISPOSABLE PROTECTION SHEETAugust 2021December 2024Abandon4140YesNo
17381717ABSORBENT ARTICLE WITH WAIST CONTAINMENT MEMBER AND METHOD OF MANUFACTURING THEREOFJuly 2021April 2025Allow4410YesNo
17344668ARRANGEMENTS AND METHODS FOR AVOIDING SPREADING OF INFECTIOUS AGENTS AND IMPROVING ELECTRIC SAFETY AND SUCTION PERFORMANCE OF A MEDICAL ASPIRATORJune 2021February 2025Allow4440NoNo
17337069PRESERVATIVE REMOVAL FROM EYE DROPSJune 2021February 2025Allow4510YesNo
17335316HEMORRHAGE MANAGEMENT SYSTEMJune 2021October 2023Allow2810YesNo
17314699OCULAR IMPLANTS FOR DELIVERY INTO AN ANTERIOR CHAMBER OF THE EYEMay 2021January 2024Allow3310NoNo
17239869OXYGENATOR UNIT WITH A PRESSURE RELIEF VALVEApril 2021April 2024Allow3610NoNo
17230547STERILE URINARY CATHETER PACKAGE WITH DISPENSING SYSTEMApril 2021April 2024Allow3600YesNo
17224311EYEDROPPER BOTTLE HOLDERApril 2021June 2023Allow2600YesNo
17220706NEGATIVE-PRESSURE THERAPY WITH ADJUSTABLE INSTILLATION PUMP CHAMBERApril 2021July 2024Allow4011NoNo
17210766Cleansing DeviceMarch 2021January 2025Abandon4601NoNo
17178285THREE-DIMENSIONAL SUBSTRATE AND ABSORBENT ARTICLES COMPRISING THE SAMEFebruary 2021January 2025Abandon4720NoNo
17147196PIEZOELECTRIC DISPENSER WITH REPLACEABLE AMPOULEJanuary 2021March 2024Allow3820YesNo
17141937SYSTEMS AND METHODS FOR REDUCING PRESSURE AT AN OUTFLOW OF A DUCTJanuary 2021June 2023Allow3010NoNo
17141101FLUID COLLECTION SYSTEMSJanuary 2021April 2024Allow3930NoNo
17115446TEMPLATE AND METHOD FOR REMOVING A TATTOO THROUGH PATTERNED TRANS-EPIDERMAL PIGMENT RELEASEDecember 2020April 2024Allow4110YesNo
17103522DEVICES AND METHODS FOR PLACING A GASTROINTESTINAL DEVICENovember 2020November 2023Allow3611YesNo
17050106WOUND DRESSING FOR TREATMENT OF DAMAGED SKINOctober 2020April 2025Allow5320NoNo
17044535SYSTEMS AND METHODS FOR DETERMINING BLOCKAGES IN A NEGATIVE PRESSURE WOUND THERAPY SYSTEMOctober 2020June 2023Allow3230YesNo
17011709Dispenser Actuator AssemblySeptember 2020July 2024Allow4711NoNo
16927349SYRINGE FILLING DEVICE FOR FAT TRANSFERJuly 2020October 2023Abandon4010NoNo
16919541APERTURED NONWOVEN WEBSJuly 2020April 2024Allow4530NoNo
16917308ABSORBENT CORE, ARTICLES COMPRISING SAID CORE, AND METHODS OF MAKINGJune 2020November 2023Allow4120YesNo
16891594COMBINATION FLUID INSTILLATION AND NEGATIVE PRESSURE DRESSINGJune 2020October 2023Allow4111NoNo
16887677WOUND DRESSING AND METHOD OF TREATMENTMay 2020September 2024Abandon5240YesYes
16876088ATTACHABLE TIP FOR ULTRASOUND HAND PIECEMay 2020December 2021Allow1920YesYes
16859115SANITARY PADApril 2020January 2021Allow910NoNo
16758783ABSORBENT ARTICLEApril 2020July 2024Allow5120NoNo
16757926ABSORBENT ARTICLE AND METHOD FOR MANUFACTURING AN ABSORBENT ARTICLEApril 2020September 2023Allow4190YesNo
16843007Disposable Absorbent Garment With Improved ElasticationApril 2020December 2024Abandon5721NoNo
16832270ABSORBENT ARTICLE HAVING IMPROVED COMFORTMarch 2020November 2024Allow5530NoNo
16831555DEVICES AND METHODS FOR DELIVERY OF PHARMACEUTICAL COMPOSITIONSMarch 2020October 2021Allow1940YesNo
16649340PH SENSING FOR SENSOR ENABLED NEGATIVE PRESSURE WOUND MONITORING AND THERAPY APPARATUSESMarch 2020December 2022Allow3320YesNo
16814895CONTAINER FOR A SOLUTION OF HUMAN PLASMA PROTEINS AND METHOD FOR OBTAINING THEREOFMarch 2020June 2022Allow2700YesNo
16645308ABSORBENT ARTICLE WITH IMPROVED FLUID HANDLINGMarch 2020May 2023Abandon3810NoNo
16645258ABSORBENT ARTICLE WITH IMPROVED FLUID HANDLINGMarch 2020March 2023Abandon3610NoNo
16645316ABSORBENT ARTICLEMarch 2020September 2023Allow4230YesNo
16795816SYSTEMS AND METHODS FOR INCREASING ABSORBENT CAPACITY OF A DRESSINGFebruary 2020January 2023Abandon3510NoNo
16787437Pant-Type Wearable ArticleFebruary 2020July 2024Allow5330YesNo
16784044DEVICES AND METHODS FOR SKIN TREATMENTFebruary 2020September 2023Allow4351YesNo
16752774NEGATIVE PRESSURE DEVICE AND METHODJanuary 2020July 2023Abandon4210NoNo
16634534CUSTOMIZABLE WOUND CLOSURE DEVICE AND METHOD OF USEJanuary 2020December 2022Allow3430YesNo
16632142ABSORBENT SHEET AND DISPOSABLE WEARING ARTICLE INCLUDING ABSORBENT SHEETJanuary 2020April 2024Allow5130YesNo
16744011FLEXIBLE MEDICAL CONTAINERS AND RELATED METHODSJanuary 2020June 2023Abandon4120NoNo
16630339POLYMER FOAM MATERIAL, DEVICE & USEJanuary 2020March 2023Allow3830YesNo
16622248WOUND CLOSURE DEVICE AND METHOD OF USEDecember 2019August 2023Allow4420YesNo
16621854DEVICES AND METHODS FOR THE TREATMENT OF BODY SURFACE DISORDERSDecember 2019January 2025Allow6061YesNo
16709102Single Lumen Drainage Catheter With Extendable and Retractable DrainsDecember 2019July 2020Allow720YesNo
16707865METHOD FOR REMOVING A TATTOO THROUGH PATTERNED TRANS-EPIDERMAL PIGMENT RELEASEDecember 2019June 2023Allow4220YesYes
16704359Drainage System With O-RingDecember 2019July 2023Allow4320NoNo

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for examiner ARBLE, JESSICA R.

Patent Trial and Appeal Board (PTAB) Decisions

Total PTAB Decisions
5
Examiner Affirmed
5
(100.0%)
Examiner Reversed
0
(0.0%)
Reversal Percentile
19.0%
Lower than average

What This Means

With a 0.0% reversal rate, the PTAB affirms the examiner's rejections in the vast majority of cases. This reversal rate is in the bottom 25% across the USPTO, indicating that appeals face significant challenges here.

Strategic Value of Filing an Appeal

Total Appeal Filings
19
Allowed After Appeal Filing
4
(21.1%)
Not Allowed After Appeal Filing
15
(78.9%)
Filing Benefit Percentile
24.7%
Lower than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 21.1% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the bottom 25% across the USPTO, indicating that filing appeals is less effective here than in most other areas.

Strategic Recommendations

Appeals to PTAB face challenges. Ensure your case has strong merit before committing to full Board review.

Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.

Examiner ARBLE, JESSICA R - Prosecution Strategy Guide

Executive Summary

Examiner ARBLE, JESSICA R works in Art Unit 3781 and has examined 336 patent applications in our dataset. With an allowance rate of 67.3%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 40 months.

Allowance Patterns

Examiner ARBLE, JESSICA R's allowance rate of 67.3% places them in the 21% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.

Office Action Patterns

On average, applications examined by ARBLE, JESSICA R receive 2.25 office actions before reaching final disposition. This places the examiner in the 77% percentile for office actions issued. This examiner issues more office actions than most examiners, which may indicate thorough examination or difficulty in reaching agreement with applicants.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by ARBLE, JESSICA R is 40 months. This places the examiner in the 8% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.

Interview Effectiveness

Conducting an examiner interview provides a +26.9% benefit to allowance rate for applications examined by ARBLE, JESSICA R. This interview benefit is in the 78% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 26.3% of applications are subsequently allowed. This success rate is in the 33% percentile among all examiners. Strategic Insight: RCEs show below-average effectiveness with this examiner. Carefully evaluate whether an RCE or continuation is the better strategy.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 20.8% of cases where such amendments are filed. This entry rate is in the 18% percentile among all examiners. Strategic Recommendation: This examiner rarely enters after-final amendments compared to other examiners. You should generally plan to file an RCE or appeal rather than relying on after-final amendment entry. Per MPEP § 714.12, primary examiners have discretion in entering after-final amendments, and this examiner exercises that discretion conservatively.

Pre-Appeal Conference Effectiveness

When applicants request a pre-appeal conference (PAC) with this examiner, 85.7% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 64% percentile among all examiners. Strategic Recommendation: Pre-appeal conferences show above-average effectiveness with this examiner. If you have strong arguments, a PAC request may result in favorable reconsideration.

Appeal Withdrawal and Reconsideration

This examiner withdraws rejections or reopens prosecution in 66.7% of appeals filed. This is in the 47% percentile among all examiners. Of these withdrawals, 50.0% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner shows below-average willingness to reconsider rejections during appeals. Be prepared to fully prosecute appeals if filed.

Petition Practice

When applicants file petitions regarding this examiner's actions, 23.9% are granted (fully or in part). This grant rate is in the 14% percentile among all examiners. Strategic Note: Petitions are rarely granted regarding this examiner's actions compared to other examiners. Ensure you have a strong procedural basis before filing a petition, as the Technology Center Director typically upholds this examiner's decisions.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 42% percentile). This examiner makes examiner's amendments less often than average. You may need to make most claim amendments yourself.

Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.9% of allowed cases (in the 55% percentile). This examiner issues Quayle actions more often than average when claims are allowable but formal matters remain (MPEP § 714.14).

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • Prepare for rigorous examination: With a below-average allowance rate, ensure your application has strong written description and enablement support. Consider filing a continuation if you need to add new matter.
  • Expect multiple rounds of prosecution: This examiner issues more office actions than average. Address potential issues proactively in your initial response and consider requesting an interview early in prosecution.
  • Prioritize examiner interviews: Interviews are highly effective with this examiner. Request an interview after the first office action to clarify issues and potentially expedite allowance.
  • Plan for RCE after final rejection: This examiner rarely enters after-final amendments. Budget for an RCE in your prosecution strategy if you receive a final rejection.
  • Plan for extended prosecution: Applications take longer than average with this examiner. Factor this into your continuation strategy and client communications.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.